Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. (300501.SZ)
CNY 14.03
(0.29%)
CNY 14.03
(0.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.02 Billion | 1.01 Billion | 856.85 Million | 713.78 Million | 621.03 Million | 507.19 Million |
| Cost of Revenue | 726.01 Million | 740.93 Million | 609.81 Million | 469.97 Million | 427.52 Million | 341.49 Million |
| Gross Profit | 294.85 Million | 271.66 Million | 247.04 Million | 243.81 Million | 193.5 Million | 165.7 Million |
| Operating Expenses | 185.74 Million | 149.09 Million | 136.03 Million | 127.93 Million | 126.6 Million | 92.04 Million |
| Selling, General and Administrative Expenses | 117.17 Million | 60.49 Million | 55.48 Million | 67.43 Million | 65.76 Million | 44.94 Million |
| Research and Development Expenses | 50.35 Million | 44.49 Million | 32.87 Million | 24.29 Million | 26.43 Million | 23.26 Million |
| Other Expenses | 9.14 Million | 240.11 Thousand | -351.52 Thousand | -700.08 Thousand | -801.56 Thousand | 122.66 Thousand |
| Cost and Expenses | 911.72 Million | 890.02 Million | 745.84 Million | 597.91 Million | 554.13 Million | 433.54 Million |
| Operating Income | 109.14 Million | 122.68 Million | 117.78 Million | 119.44 Million | 73.92 Million | 76.87 Million |
| Interest Expense | 11.48 Million | 5.32 Million | 9.21 Million | 8.85 Million | 7.16 Million | 1.95 Million |
| Income Tax Expense | 14.64 Million | 13.07 Million | 8.4 Million | 13.31 Million | 7.39 Million | 12.63 Million |
| Earnings before Tax | 108.97 Million | 122.92 Million | 117.43 Million | 118.74 Million | 73.12 Million | 76.99 Million |
| Net Income | 85.44 Million | 102.46 Million | 104.64 Million | 102.9 Million | 66.97 Million | 66.16 Million |
| Earnings Per Share Basic | 0.44 | 0.53 | 0.64 | 0.67 | 0.44 | 0.44 |
| Earnings Per Share Diluted | 0.44 | 0.53 | 0.64 | 0.67 | 0.43 | 0.44 |
| Weighted Average Shares Outstanding | 194.18 Million | 193.53 Million | 163.5 Million | 153.58 Million | 152.21 Million | 150.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 194.18 Million | 193.53 Million | 163.5 Million | 153.58 Million | 155.75 Million | 150.37 Million |
| Gross Margin | 0.29 | 0.27 | 0.29 | 0.34 | 0.31 | 0.33 |
| EBIT Margin | 0.17 | 0.18 | 0.20 | 0.23 | 0.19 | 0.21 |
| Profit Margin | 0.08 | 0.10 | 0.12 | 0.14 | 0.11 | 0.13 |
| EBITDA | 175.28 Million | 178.2 Million | 154.05 Million | 162.19 Million | 113.33 Million | 104.3 Million |
| Earnings Before Tax Margin | 0.11 | 0.12 | 0.14 | 0.17 | 0.12 | 0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 276.31 Million | 288.93 Million | 256.27 Million | 257.8 Million | 1.01 Billion | 230.2 Million |
| Cost of Revenue | 196.47 Million | 204.84 Million | 183.95 Million | 179.84 Million | 726.01 Million | 160.81 Million |
| Gross Profit | 79.83 Million | 84.09 Million | 72.32 Million | 77.95 Million | 284.37 Million | 69.38 Million |
| Operating Expenses | 45.16 Million | 45.04 Million | 36.84 Million | 66.73 Million | 173.09 Million | 38.39 Million |
| Selling, General and Administrative Expenses | 71.22 Million | 32.58 Million | 28.87 Million | 40.39 Million | - | 52.17 Million |
| Research and Development Expenses | 15.75 Million | 12.77 Million | 8.32 Million | 15.44 Million | - | 10.15 Million |
| Other Expenses | -41.81 Million | 312.34 Thousand | 352.1 Thousand | -10.89 Million | -8.34 Million | -189.75 Thousand |
| Cost and Expenses | 241.63 Million | 249.88 Million | 220.79 Million | 246.58 Million | 899.1 Million | 199.21 Million |
| Operating Income | 27.98 Million | 39.04 Million | 35.47 Million | 11.22 Million | 111.28 Million | 55.15 Million |
| Interest Expense | 2.43 Million | 2.9 Million | 2.67 Million | 1.96 Million | 11.48 Million | 3.38 Million |
| Income Tax Expense | 4.64 Million | 6.18 Million | 6.21 Million | -266.64 Thousand | 14.64 Million | 5.38 Million |
| Earnings before Tax | 27.98 Million | 38.61 Million | 31.12 Million | 10.22 Million | 101.79 Million | 54.96 Million |
| Net Income | 21.86 Million | 34.84 Million | 23.01 Million | -5.59 Million | 85.44 Million | 48.11 Million |
| Earnings Per Share Basic | 0.12 | 0.18 | 0.12 | -0.03 | - | 0.25 |
| Earnings Per Share Diluted | 0.12 | 0.18 | 0.12 | -0.03 | - | 0.25 |
| Weighted Average Shares Outstanding | 182.18 Million | 192.42 Million | 193.53 Million | 193.53 Million | 193.53 Million | 193.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 182.18 Million | 192.42 Million | 193.53 Million | 193.53 Million | 193.53 Million | 193.53 Million |
| Gross Margin | 0.29 | 0.29 | 0.28 | 0.30 | 0.28 | 0.30 |
| EBIT Margin | 0.11 | 0.19 | 0.14 | 0.10 | - | 0.25 |
| Profit Margin | 0.08 | 0.12 | 0.09 | -0.02 | 0.08 | 0.21 |
| EBITDA | 30.42 Million | 54.62 Million | 34.74 Million | 25.52 Million | - | 57.13 Million |
| Earnings Before Tax Margin | 0.10 | 0.14 | 0.14 | 0.04 | 0.11 | 0.24 |
IPO
LUXHP
ORZCF
AMBP
APLE
HNST